2 results match your criteria: "Beth Israel Medical Center and Roosevelt Hospital[Affiliation]"
Prevalence of Delayed Nausea and/or Vomiting in Patients Treated With Oxaliplatin-Based Regimens for Colorectal Cancer.
J Oncol Pract
May 2012
Beth Israel Medical Center and Roosevelt Hospital, Continuum Cancer Centers of New York, New York, NY.
Purpose: To measure the prevalence of nausea and vomiting 2 to 5 days after oxaliplatin-based chemotherapy.
Patients And Methods: Sixty-four patients (55% men; 44% women) enrolled onto this cross-sectional study. Fifty-three (83%) had colon cancer and received oxaliplatin biweekly.
Segmental hemangiomas of the upper airway.
Laryngoscope
November 2009
Vascular Birthmark Institute, Beth Israel Medical Center and Roosevelt Hospital, New York, New York 10023, USA.
Objectives/hypothesis: To characterize the anatomic distribution of segmental hemangiomas of the larynx and to describe indications for treatment modalities.
Study Design: Retrospective chart review.
Methods: We performed a retrospective chart review of patients with cutaneous hemangiomas at a tertiary care center over a 4-year period.